Oral idasanutlin in patients with polycythemia vera

A limited number of drugs are available to treat patients with polycythemia vera (PV) and essential thrombocythemia (ET). We attempted to identify alternative agents that may target abnormalities within malignant hematopoietic stem (HSCs) and progenitor cells (HPCs). Previously, MDM2 protein levels...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Mascarenhas, John, Lu, Min, Kosiorek, Heidi, Virtgaym, Elizabeth, Xia, Lijuan, Sandy, Lonette, Mesa, Ruben, Petersen, Bruce, Farnoud, Noushin, Najfeld, Vesna, Rampal, Raajit, Dueck, Amylou, Hoffman, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2019
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688433/
https://ncbi.nlm.nih.gov/pubmed/31167802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2018893545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados